Clinical trial
A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of Additional Sizes of the BioFreedom Ultra CoCr Biolimus A9 Coated Coronary Stent System
NCT05643430 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Single Arm Trial to Assess the Safety and Effectiveness of Additional Sizes of the BioFreedom Ultra CoCr Biolimus A9 Coated Coronary Stent System
- Lead sponsor
- Biosensors Europe SA
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 27, 2024
- Completion date
- August 31, 2026
- Enrollment
- 86 (estimated)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, high bleeding risk patients